Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Up 14.3% in June

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the recipient of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 1,600 shares, a growth of 14.3% from the June 15th total of 1,400 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

Laboratorios Farmaceuticos Rovi stock opened at C$90.61 on Wednesday. The firm has a 50-day moving average of C$87.05 and a 200-day moving average of C$74.65. Laboratorios Farmaceuticos Rovi has a 1-year low of C$90.61 and a 1-year high of C$90.61.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.